Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 0.97% today. In the last week its performance is -2.22%, and 6.81% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 468.41, so today’s gain of 0.97% is a significant step towards its target price. The GAP today is therefore 0.57%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 41315.91, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 71.10%.

At the current price of 393.86, it has a dividend yield of *TBA, and its target price is 468.41. This is with a profit margin of 16.00%, and total debt/equity of 0.09. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 61.48, as well as a forward P/E of 27.17.

With a current EPS of 6.41, and a forecasted EPS growth for next year at 31.23%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 18.62%.

Performance for the year is -21.84%. Since its IPO date on 4/2/1991, the total performance to date is -27.45%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 729100, while its average volume is 742.42. Whilst the total gain today was 0.97%, it did have a day high of -11.29%.

Volatility for this week has been at 2.08%, and 2.58% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 19.68%, while the 52-week-high has reached -33.54%.

Looking at its return of investments, which is 16.00%, and its return on assets is 13.00%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 26.70%. With a sales growth of 21.40% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.09, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.3, and the P/S is 8.89, along with a P/B of 10.11. Meanwhile it has a p/cash of 39.53.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment